NHAM ASM 2015: Practical evidence-based cardiology for your patients Day 1, Friday 10 April 2015 Venue: Hilton Kuala Lumpur & Le Meridien Kuala Lumpur

Transcription

1 NHAM ASM 2015: Practical evidence-based cardiology for your patients Day 1, Friday 10 April 2015 Venue: Hilton Kuala Lumpur & Le Meridien Kuala Lumpur Time Ballroom C From guidelines to practice: an interactive case-based symposium Help me doctor! I am breathless: is it heart failure? Moderator: Sazzli KASIM Case presenter: Johan Rizwal ISMAIL Expert panellists: ONG Tiong Kiam, Sree RAMAN Special Lecture 1 Chairperson: Azhari ROSMAN Nik Zainal Memorial Lecture: The Cholesterol Story from observation to hypothesis to translational science: A tribute to Dato Dr Khoo Kah Lin David QUEK 2. European Society of Cardiology Initiatives in Malaysia and Asia Thierry GILLEBERT 3. European Society of Cardiology Lecture: A timely reminder of the unknown: Prognostic stratification of HFpEF Thierry GILLEBERT Opening Ceremony MC: Azmee GHAZI Launching of the NHAM Appropriateness Use Criteria Special Lecture 2 Chairperson: ROSLI Mohd Ali American College of Cardiology Initiatives in Malaysia and Asia Robert HENDEL 2. American College of Cardiology Lecture: Appropriate use of cardiovascular technology Robert HENDEL

2 Tea Break Symposium 1 Antiplatelet therapy in daily practice Ballroom B Ballroom C Clarke Ballroom Concurrent Symposia Symposium 2 Symposium 3 SCIM Symposium: Hypertension in 2015 Multi modality approach in the management of aortic stenosis TIANG Soon Wee LIEW Houng Bang Ahmad KHAIRUDDIN Mohd Rahal YUSOFF Azhari ROSMAN Asri SAID Concurrent Free Papers Antiplatelet agents for primary prevention: Evidence and uncertainties Oteh MASKON 1. Echo: Is this all you need? Mohd Rahal YUSOFF 1. Cardiovascular protection in hypertensive diabetics with RAS inhibition: What's the target? Martin STRAUSS 1. Arrhythmias & Imaging FP1.1 FP1.6 (Sentral Accord, Hilton KL) CHONG Wei Peng Ravinderjit SINGH Optimising antiplatelet therapy in clinical practise for ACS and beyond Arthur TAN 2. CT: Where are we in aortic stenosis? CHUA Seng Keong 2. When and how to safely use RAS inhibitors in patients with CKD and hypertension? Sunita BAVANANDAN 2. Interventional Cardiology 1 FP2.1 FP2.6 (Sentral Exchange, Hilton KL) Zulhilmi YAACOB Anuar MASDUKI Use of concomitant antiplatelet with anticoagulant therapy Razali OMAR 3. CMR: Where should I come in? Nor Hanim MOHD AMIN 3. New and novel treatments for hypertension- What does the future hold? Abdul Rashid ABDUL RAHMAN 3. General Cardiology 1 FP3.1 FP3.6 (Parry 1, Le Meridien KL) David QUEK MA Soot Keng

3 Time Ballroom B Clarke Ballroom Lunch Symposium 1 Lunch Symposium 3 SERVIER Astra ZENECA Chairperson: Chua Seng Keong Chairperson: Choong Choon Hooi Survival at the heart of hypertension management: ACE inhibitors vs ARBs Martin STRAUSS 2. ADVANCE-ON in the management of the diabetic hypertensive patients YAP Piang Kian 1. Ischaemic Heart Disease in Diabetes: How can we reduce the risk further Khalid KADIR 2. Kombiglyze XR: Harnessing Synergistic Evidence Towards CV Risk Reduction CHAN Siew Pheng Time Ballroom B Ballroom C Clarke Ballroom Concurrent Symposia Symposium 4 Symposium 5 Symposium 6 Acute Heart Failure STEMI Initiatives in Malaysia Joint NHAM-FMSA Symposium Omar ISMAIL Aizai Azan ABDUL RAHIM CHOO Gim Hooi Mohd Rahal YUSOFF Abdul Kahar GHAPAR Sree RAMAN Concurrent Free Papers

4 Decompensated acute heart failure: Current management and future perspectives David SIM 1. STEMI Care In 2015 and the importance of STEMI networks Robaayah ZAMBAHARI 1. Overall CV risk assessment: Relevance, how, which and when? CHIA Yook Chin 4. General Cardiology 2 FP5.1 FP5.6 (Parry 1, Le Meridien KL) Azhari ROSMAN N. ARUMUGAM What s new in the management of cardiogenic shock? Simon LO 3. Now to prevent them coming back! Preventing readmissions in heart failure David SIM 2. STEMI networks in Malaysia Omar ISMAIL 3. Early real world experience with STEMI networks Al Fazir OMAR 2. Tracking primary dyslipidaemia in primary care setting using teleprimary care Ruziaton HASIM 3. Contemporary targets for lipid and blood pressure control: Evidence and uncertainties Kevin JOSEPH 5. Interventional Cardiology 2 FP4.1 FP4.6 (Sentral Exchange, Hilton KL) Hendrick CHIA LAM Kai Huat 6. Allied Health FP6.1-FP6.4 (Parry 2, Le Meridien KL) Zubin IBRAHIM YAP Lok Bin Tea Break Time Ballroom B Ballroom C Clarke Ballroom Concurrent Symposia Symposium 7 Venous Thromboembolism Symposium 8 Frontier technology in cardiology Symposium 9 Malaysian Society of Atherosclerosis Symposium Zul Hilmi YAACOB Oteh MASKON Chairperson: Al Fazir OMAR Simon LO N. ARUMUGAM CHUA Seng Keong

5 Are we doing enough for VTE prophylaxis in our patients? Hanafiah HARUNARASHID 1. The Parachute device for heart failure- the Malaysian experience Robaayah ZAMBAHARI 1. The 2013 ACC AHA lipid guidelines in our clinical practice: Lessons from Kah Lin Arthur TAN Update of the latest ESC guidelines on acute pulmonary embolism Thierry GILLEBERT 2. Genetic testing in cardiology Asri SAID 2. PCSK-9: The future of cholesterol reduction? Sazzli KASIM NOAC in the treatment of VTE- Is it safe and effective? NG Heng Joo 3. Bioresorbable vascular scaffolds: Hope or hype? Rajesh SHAH 3. Newer antidiabetic agents in the cardiovascular milieu Nor Azmi KAMAURDDIN

6 Day 2, Saturday 11 th April 2015 Venue: Hilton Kuala Lumpur & Le Meridien Kuala Lumpur Time Ballroom C From guidelines to practice: An interactive case-based discussion A diabetic patient with chest pain: How would I manage? Moderators: Imran ZAINAL ABIDIN, CHEE Kok Han Case presenter: Muhammad Dzafir ISMAIL Expert panels: Rajesh SHAH, Oteh MASKON, Time Ballroom B Ballroom C Clarke Ballroom Accord Network Room Concurrent Symposia Symposium 10 Symposium_12 Chronic heart failure NHAM-WH2O Symposium: Azmee GHAZI David CHEW Symposium11 NHAM-ACC Symposium: Imaging in cardiac ischemia Ahmad KHAIRUDDIN ROSLI Mohd Ali Jeyamalar RAJADURAI Emily TAN Lay Koon Symposium 13 Procedures in practice: How to do it! Chairperson: Asri Ranga ABDULLAH RAMAIAH Abdul Wahab UNDOK Snoring : More than just a nuisance Imran ZAINAL ABIDIN 1. How echocardiography can help in acute coronary syndromes LAM Kai Huat 1. Peripartum cardiomyopathy: An update CHEE Kok Han 1. How to prepare and perform electrical cardioversion? Saravanan KRISHNAN What is the role of biomarkers in 2015? Alan FONG 3. ARNI: A true paradigm shift in heart failure management? John MCMURRAY 2. Testing for viability and ischaemia in patients with severe LV impairment Robert HENDEL 3. Appropriate and effective use of CT in cardiac ischaemia ONG Tiong Kiam 2. Non-obstructive coronary artery disease (microvascular angina): Diagnosis and treatment Emily TAN Lay Koon 3. Preventive strategies in the older woman ONG Mei Lin 2. How to do a needle pericardiocentesis? Muhamad Ali SK ABDUL KADER 3. Temporary pacing wire: When is it indicated, when its not, and how to do it MA Soot Keng

7 Symposium 14 Challenging scenarios in clinical cardiology Taworn SUITHICHAIYAKUL YAP Lok Bin Symposium 15 NHAM- ESC SYMPOSIUM Cardiology in an Aging population ROSLI Mohd Ali NG Wai Kiat Symposium 16 Controversies in cardiology CHONG Yoon Sin CHAN Chong Guan Symposium 17 Pharmacists Symposium: Chairperson: Lawrence ANCHAH Alan FONG The patient with recent DES needing non-cardiac surgery LIEW Chee Tat 1. Aortic stenosis in the elderly patient: What are our options? Shaiful Azmi YAHAYA 1. Beta-blockers in hypertension and angina: What is their place? CHANG Sau Kong 1. Transformation of healthcare system: Where are we now? Abida Haq Syed M HAQ Pyrexia of unknown origin: A patient with endocarditis and ASD LIM Bee Chian 3. When and how to assess for chemotherapeutc cardiotoxicity LAM Kai Huat 2. The mechanics of diastolic function: State of the art Thierry GILLEBERT 3. Treatment of systolic LV dysfunction in the geriatric population: What are the difficulties and solutions? John MCMURRAY 2. Statins in lower risk patients: Benefit or harm? CHOO Gim Hooi 3. Maximizing benefit, minimizing harm: Anticoagulation use in elderly patients with AF Razali OMAR 2. Myth of smoking cessation therapy in CAD Mohamad Haniki NIK MOHAMED 3. E.A.T: Impact on selecting generics LEE Toong Chow Tea Break

8 Ballroom B Ballroom C Clarke Ballroom Parry Symposium 19 Symposium 20 Get with the guidelines! Public Health Symposium: Highlights of Malaysian Implementation of research in CPG NCD in Malaysia Omar ISMAIL Anis Safura RAMLI TIANG Soon Wee Feisul Idzwan MUSTAPHA Symposium 18 Diabetes and cardiovascular diseases LIEW Chee Tat Alexander TAN Young Investigator Award Paper Presentations Nik Halmey NIK ZAINAL ABIDIN Alan FONG Cardiovascular risk with oral diabetic therapy: What does the evidence tell us? YAP Piang Kian 1. CPG on ST elevation MI Robaayah ZAMBAHARI 1. HOPE-4: Cluster randomised trial of a model CV risk assessment and management programme Khalid YUSOFF Insulin: Who needs it, and how to do it safely Shireene VETHAKKAN 2. CPG on Heart failure Jeyamalar RAJADURAI 2. JOM MAMA - Pre-pregnancy intervention among young couples to reduce risk of NCD in later life Ramli ZAINAL YIA YIA YIA YIA YIA YIA Revascularisation in diabetic patients: What does the evidence say? Hamat HAMDI 3. CPG on Hypertension Abdul Rashid ABDUL RAHMAN 3. MyBFF@home - An intervention study to combat obesity among housewives in the Klang Valley. Noor Safiza MOHD NOR Ballroom B Ballroom C Clarke Ballroom

9 Lunch Symposium 4 Boehringer Ingleheim Chairperson: Razali OMAR 1. Optimising Protection after an Ischemic Stroke Andrew WONG 2. Considering the bigger the picture: Practical Insights for Patient Management CHEE Kok Han 3. The Journey Continues: Looking Ahead with Dabigatran Raymond WONG Lunch Symposium 5 BAYER Chairperson: Muhamad Ali SK ABDUL KADER 1. Decision-Making in Anticoagulation in Atrial Fibrillation: Patient Considerations Pipin KOJODJOJO 2. Case Study Pipin KOJODJOJO Lunch Symposium 6 MSD Chairperson: David QUEK 1. Improve IT Alberico L. CATAPANO 2. Pre-TECOS on diabetes management Robaayah ZAMBAHARI Time Ballroom B Ballroom C Clarke Ballroom Parry Concurrent Symposia Symposium 23a Symposium 21 Symposium 22 Symposium 23 NHAM Appropriateness Use Focus session: NHAM-College of Emergency Stable Angina Criteria The practicalities of Physicians Joint Symposium anticoagulant therapy in Robaayah ZAMBAHARI SPAF YEO Chee Kian Asri Ranga ABDULLAH RAMAIAH Robert HENDEL Sabariah Faizah JAMALUDDIN Ravinderjit SINGH Ahmad Nizar JAMALUDDIN Ernest NG Wee Oon

10 Introduction and Methology Jeyamalar RAJADURAI 1. Out of Hospital Cardiac arrest and resuscitation Mohd Idzwan ZAKARIA 1. How to assess the asymptomatic individual in 2015: Who needs revascularisation? Sanjiv JOSHI 1. NOAC use in Malaysia: What does the data tell us? YAP Lok Bin Multimodality Appropriateness Use Criteria for the diagnosis and Risk Assessment of patients with stable CAD Mohd Rahal YUSOFF 2. Optimising post resuscitation care: Therapeutic hypothermia, circulatory support Adi OSMAN 2. What exactly is optimal medical therapy in 2015? Azani DAUD 2. Bleeding with NOACS: What should I do? Raymond WONG Appropriateness Use Criteria for Coronary Revascularisation in STEMI Wan Azman WAN AHMAD 4. Appropriateness Use Criteria for Coronary Revascularization in UA/NSTEMI and Stable CAD. AUC for Mode of Coronary Revascularisation and for Ad Hoc PCI David CHEW 3. How to improve STEMI door-to-treatment time in real-world Malaysia? LIEW Houng Bang 3. Defining the role of heart rate reduction in 2015 Thierry GILLEBERT 3. What should I do for AF patients with renal impairment? MA Soot Keng Tea Break Time Ballroom B Ballroom C Clarke Ballroom Symposium 24 Symposium 25 How to manage a patient with newly Managing cardiovascular risk in noncardiac diagnosed AF: surgery Step by step case-based symposium Razali OMAR Nik Halmey NIK ZAINAL ABIDIN MA Soot Keng Zubin IBRAHIM Symposium 26 Cardiac rehab, sport and exercise Aizai Azan ABDUL RAHIM Emily TAN Lay Koon

11 Diagnosis KOH Kok Wei 1. Clinical assessment of perioperative cardiovascular risk: How to do it? Effarezan ABDUL RAHMAN 1. Jom ubah! Why do we continue to neglect exercise as therapy? Anwar SUHAIMI Risk assessment of thromboembolism and bleeding Saravanan KRISHNAN 2. Appropriate use of cardiac imaging and testing in risk assessment Robert HENDEL 2. Cardiovascular changes with extreme exercise: Can you get too much of a good thing? POH Kian Keong Treatment options Andrew WONG 3. Risk reduction with medical therapy and revascularization: What does the evidence say? ONG Mei Lin 3. Assessment of risk of sudden death in athletes Mohd Rahal YUSOFF

12 Day 3, Sunday 12 th April 2015 Venue: Hilton Kuala Lumpur & Le Meridien Kuala Lumpur Time Ballroom C Clarke Ballroom Concurrent Symposia Symposium 27 Symposium 28 The Sunday Morning SOPACE ECG Show The obesity tsunami Part 1 Nik Asmah NIK HUSSAIN Razali OMAR VANG chu Imran ZAINAL ABIDIN ECG in patients with palpitations KOH Kok Wei 1. The size of the problem, and update on medical therapy Zanariah HUSSAIN Common normal variants on the resting ECG Surinder KAUR 3. The ECG in ST elevation MI: You don t want to miss this! Ahmad Fazli ABDUL AZIZ 2. Partnering with your dietician for patients' successful weight loss Mary EASAW 3. Bariatric surgery for weight loss and diabetes Nik Ritza Kosai NIK MAHMOOD Symposium 29 The Sunday Morning SOPACE ECG Show Part 2 Razali OMAR Imran ZAINAL ABIDIN 1. ECG quiz: The answers and explanation Razali OMAR, Imran ZAINAL ABIDIN Surinder KAUR MA Soot Keng KOH Kok Wei Symposium 30 How to manage resistant and recurrent diseases in my practice? Nik Halmey NIK ZAINAL ABIDIN TING Chih Kuan 1. How to assess the patient with resistant hypertension? ONN Akbar Ali 2. What to do for the patient with frequent decompensated heart failure readmissions? David CHEW 3. How to assess and manage the patient with persistently elevated LDL-Cholesterol Alberico L. CATAPANO

13 Tea Break Symposium 31 The top three late-breaking trials at recent Cardiology meetings Alan FONG Nik Halmey NIK ZAINAL ABIDIN Symposium 32 Sex and Smoking: How to help your patients! Zubin IBRAHIM TIANG Soon Wee ESC 2014 Wan Azman WAN AHMAD 1. E-cigarettes: What should we tell our patients? Aizai Azan ABDUL RAHIM ACC 2015 Azhari ROSMAN 3. Intervention 2015 ROSLI Mohd Ali CLOSING CEREMONY and PRIZE PRESENTATION 2. Smoking cessation strategies in 2015 Helmy HAJA MYDIN Closing Ceremony and Prize Giving (Ballroom C) 3. Sex and the cardiac patient: What your patient will ask you! Betty TEH Bee Tee